Healthcare Loc ShareCast News (HLO)

Small caps round-up: ReNeuron, Eckoh, Healthcare Locums

Clinical-stage stem cell group ReNeuron surged on Tuesday after saying that the Data Safety Monitoring Board gave a favourable recommendation to proceed to the with a higher dose of its ReN001 stem cell therapy in a clinical trial. 'This represents a further important milestone for the study as we make our plans for a subsequent Phase II clinical trial application with ReNeuron's ReN001 cell-based treatment for stroke disability,' said ReNeuron's Chief Executive Michael Hunt.
[14 Aug '12]

Small caps round-up: Acta, Healthcare Locums, NCC

Clean energy products company Acta has said it is pleased with Taiwan's Ministry of Economic Affairs decision to approve the safety and reliability standards for fuel cell scooters and motorcycles, meaning they are now ready for mass production. Acta said it believes that the release of road standards for fuel cell motorcycles and scooters will help to accelerate the introduction and adoption of these vehicles together with the refuelling kiosk within tourist destinations and
[2 Aug '12]

Healthcare Locums up as US legal wrangle ends

Healthcare Locums, the troubled nursing, medical and social services recruitment firm has had some good news on the legal front.
[20 Jun '12]

Lamprell director sells another load of shares

A round-up of the biggest director deals today so far.
[3 May '12]

Small caps round-up: Imaginatik, Braveheart, Healthcare Locums...

Imaginatik has signed a new annual contract with a leading provider of healthcare services and medical research in the US.
[29 Feb '12]

Small caps round-up: Caza, Tower Resources, Noventa...

Mining firm Noventa says that operations have suffered from a "plague" of beetles as a result of tropical storms which have hit the firm's Marropino site in Mozambique over the past 10 days. The Rove Beetle is very poisonous and around 30% of the workforce at Marropino have been affected by the severe skin and eye irritations caused by coming into contact with the insects. The firm was keen to emphasise that an effective treatment has now been administered and a pesticide is being sprayed to erradicate the infestation. Progress at Marropino has been delayed and is set to start in March, a delay of around a month. Shares dropped 2.78% to 17.5p.
[2 Feb '12]

Healthcare Locums outlines survival plan

Troubled medical staff provider Healthcare Locums has outlined plans for the refinancing of the company.
[19 Aug '11]

Healthcare Locums looks to restore confidence but uncertainty lingers

Scam-hit Healthcare Locums (HCL) hoped to soothe investor jitters by saying the majority of its UK operations are sound and it is considering refinancing opportunities to stabilise its capital structure, but the on-going probe has cast a shadow over the validity of its prior year results.
[29 Jun '11]